drugset / Trial / NCT01923597

Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.

NCT01923597

Phase 2 Completed 50 enrolled University of Campinas, Brazil
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the safety and effect of green tea (epigallocatechin gallate) in albuminuria in diabetic patients and nephropathy.

Timeline

Start
2013-11
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epigallocatechin gallate Small molecule 800 mg Oral